The high prevalence of anti-hepatitis C virus (HCV) antibodies in HD patients has been known since the early 1990s but its evolution over the last decade is poorly documented.
M.D., Cliniques Universitaires St Luc, Department of Nephrology, Université catholique de Louvain, Avenue Hippocrate 10, B-1200 Brussels, Belgium. jadoul@nefr.ucl.ac.be
